European Commission Grants Marketing Authorization for Moderna's MCOMBRIAX Vaccine
Moderna has received marketing authorization from the European Commission for MCOMBRIAX, its mRNA combination vaccine against influenza and COVID-19. This enables distribution in European markets. The vaccine targets respiratory viruses with combined protection.
:format(webp)/https://www.thestar.com/content/dam/thestar/news/world/europe/2022/09/30/suspicious-white-powder-found-at-eu-commission-building/2022093011090-633704da0e4c200aa59655cajpeg.jpg)
thestar.comThe European Commission has granted marketing authorization for MCOMBRIAX, Moderna's mRNA combination vaccine against influenza and COVID-19, @FirstSquawk reported. Moderna received the authorization, which allows the company to distribute MCOMBRIAX in European markets. MCOMBRIAX is an mRNA combination vaccine developed by Moderna to combat both influenza and COVID-19.
The authorization represents progress in efforts to address respiratory viruses through combined vaccination.
Key Facts
Story Timeline
4 events- 2026-04-21
European Commission grants marketing authorization for MCOMBRIAX to Moderna.
1 source@FirstSquawk - Recent (prior to 2026-04-21)
Moderna develops MCOMBRIAX as an mRNA combination vaccine against influenza and COVID-19.
1 source@FirstSquawk - Recent (prior to authorization)
Authorization enables distribution of MCOMBRIAX in European markets.
1 source@FirstSquawk - Ongoing
MCOMBRIAX targets combined protection against respiratory viruses.
1 source@FirstSquawk
Potential Impact
- 01
Increased availability of combined vaccines in Europe, potentially boosting vaccination rates.
- 02
Advancement in public health strategies against influenza and COVID-19.
- 03
Potential revenue growth for Moderna from European market distribution.
- 04
Possible influence on global vaccine development trends for respiratory diseases.
Transparency Panel
Related Stories
NASA / Harrison H. Schmitt / Wikimedia (Public domain)NASA Releases Thousands of Photos from Artemis II Lunar Mission
NASA has released over 12,000 images from the Artemis II mission, which orbited the moon in April 2026. The photos capture views of Earth, the lunar surface, and a solar eclipse observed during the crew's return. Astronauts from the mission also visited the United Nations headqua…
deccanchronicle.comHantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Risk
A hantavirus outbreak on the MV Hondius cruise ship has killed three passengers and sickened seven others, prompting an international response coordinated by the World Health Organization. The ship, carrying 147 people from 23 nationalities, is set to sail to Spain's Canary Islan…
newscientist.comHoutman Abrolhos Corals Show High Resilience to 2025 Heatwave, Unlike Global Losses
Coral reefs at the Houtman Abrolhos Islands off Western Australia endured a prolonged heatwave in early 2025 virtually unscathed, unlike widespread global die-offs. Researchers found exceptional heat tolerance across multiple species, with lab tests showing survival rates far exc…